Nicolas Wolikow
Chief Executive Officer, Cure51 (France)
Over 20 years operating as a Managing Director and revenue generation, digital business development and strategic leadership experiences within start-ups and multinational firms. Forward-thinking executive with a strong ability to lead and motivate worldwide teams comprising of more than 400 employees. Managing P&L for
business divisions exceeding $200M revenue. Appetite for management, ops and strategy implementation for global transformation. Passionate about healthcare innovations that shape new patients and Kol’s experiences.